Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
BLONDER TONGUE LABORATORIES INC (BDR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/06/2022 |
8-K
| Quarterly results |
| 03/31/2022 |
8-K
| Quarterly results |
| 10/22/2021 |
8-K
| Quarterly results|
Docs:
|
"Blonder Tongue Announces Third Quarter and Nine- Month 2021 Results OLD BRIDGE, NJ / October 22, 2021 / Blonder Tongue Laboratories, Inc. announced its sales and results for the third quarter and nine months ended September 30, 2021. Blonder Tongue Laboratories, Inc. net sales increased $1,000 or 0.02% to $4,172,000 for the third quarter of 2021 from $4,171,000 for the comparable period in 2020. Net loss for the three months ended September 30, 2021, was $ or $ per diluted share, compared to a net loss of $ or $ per diluted share for the comparable period in 2020. Commenting on the third quarter results, Ted Grauch, Blonder Tongue Laboratories’ President and CEO noted, “The Company made strong progress in the third quarter on several fronts. We’ ve continued to grow sales of our high techn..." |
|
| 08/12/2021 |
8-K
| Quarterly results|
Docs:
|
"Blonder Tongue Announces Second Quarter and Six Months 2021 Results OLD BRIDGE, NJ / August 12, 2021 / Blonder Tongue Laboratories, Inc. announced its sales and results for the second quarter and six months ended June 30, 2021. Blonder Tongue Laboratories, Inc. net sales increased $507,000 or 13.2% to $4,338,000 for the second quarter of 2021 from $3,831,000 for the comparable period in 2020. Net income for the three months ended June 30, 2021, was $1,626,000 or $0.11 per diluted share, compared to a net loss of $ or $ per diluted share for the comparable period in 2020. Commenting on the second quarter results, Ted Grauch, Blonder Tongue Laboratories’ President and CEO noted, “In Q2 the Company saw several elements of our long-term strategy begin to come together yielding a positive first..." |
|
| 05/13/2021 |
8-K
| Quarterly results |
| 03/12/2021 |
8-K
| Quarterly results |
| 08/07/2020 |
8-K
| Quarterly results |
| 05/15/2020 |
8-K
| Quarterly results|
Docs:
|
"Blonder Tongue Reports First Quarter 2020 Results OLD BRIDGE, NJ / May 15, 2020 / Blonder Tongue Laboratories, Inc. announced its sales and results for the first quarter ended March 31, 2020. Net sales decreased $32,000 or 0.8% to $4,050,000 for the first quarter of 2020 from $4,082,000 for the comparable period in 2019. Net loss for the three months ended March 31, 2020 was $ or $ per diluted share, compared to net earnings of $5,325,000 or $0.53 per diluted share for the comparable period in 2019. The decrease in net earnings for the first quarter 2020, relative to the first quarter 2019, is primarily driven by the $7,175,000 gain recognized in the first quarter of 2019, upon the consummation of the sale and leaseback transaction of our headquarters facility in Old Bridge, New Jersey. Th..." |
|
| 04/09/2020 |
8-K
| Quarterly results|
Docs:
|
"Blonder Tongue Reports Fourth Quarter and Year End 2019 Results OLD BRIDGE, NJ / April 9, 2020 / Blonder Tongue Laboratories, Inc. announced its sales and results for the fourth quarter and year ended December 31, 2019. Net sales decreased $396,000 or 7.3% to $5,045,000 for the fourth quarter of 2019 from $5,441,000 for the comparable period in 2018. Net loss for the three months ended December 31, 2019 was $ or $ per share, compared to $ or $ per share for the comparable period in 2018. The decrease in sales is primarily attributed to a decrease in sales of DOCSIS data products, digital video headend products, HFC distribution products and analog video headend products offset by an increase in sales of NXG IP video signal processing products and CPE products. Sales of DOCSIS data products..." |
|
| 11/06/2019 |
8-K
| Quarterly results |
| 08/14/2019 |
8-K
| Quarterly results|
Docs:
|
"Blonder Tongue Reports Second Quarter 2019 Results OLD BRIDGE, NJ / August 14, 2019 / Blonder Tongue Laboratories, Inc. announced its sales and results for the second quarter and six months ended June 30, 2019. Net sales increased $160,000 or 3.0% to $5,437,000 for the second quarter of 2019 from $5,277,000 for the comparable period in 2018. Net loss for the three months ended June 30, 2019 was $ or $ per share, compared to $ or $ per share for the comparable period in 2018. The increase in sales was primarily attributed to an increase in sales of set top box products and NeXgen Gateway products, offset by a decrease in sales of data products, digital video headend products, contract manufactured products and HFC distribution products. Sales of set top box products were $1,002,000 and zero..." |
|
| 05/15/2019 |
8-K
| Quarterly results|
Docs:
|
"Blonder Tongue Reports First Quarter 2019 Results OLD BRIDGE, NJ / May 15, 2019 / Blonder Tongue Laboratories, Inc. announced its sales and results for the first quarter ended March 31, 2019. Net sales decreased $1,281,000 or 23.9% to $4,082,000 for the first quarter of 2019 from $5,363,000 for the comparable period in 2018. Operating loss was $ for the three months ended March 31, 2019, compared to operating income of $87,000 for the comparable period in 2018. Net income for the first quarter of 2019 was $5,325,000 or $0.53 per diluted share, compared to a net loss of $ or $ per diluted share for the comparable period in 2018. Included in the net income for the three months ended March 31, 2019, was a gain of $7,175,000 related to the sale/leaseback of the Old Bridge Facility. The decreas..." |
|
| 04/01/2019 |
8-K
| Quarterly results|
Docs:
|
"Blonder Tongue Reports Fourth Quarter and Year End 2018 Results OLD BRIDGE, NJ / April 1, 2019 / Blonder Tongue Laboratories, Inc. announced its sales and results for the fourth quarter and year ended December 31, 2018. Net sales decreased $129,000 or 2.3% to $5,441,000 for the fourth quarter of 2018 from $5,570,000 for the comparable period in 2017. Net loss for the three months ended December 31, 2018 was $ or $ per share, compared to $ or $ per share for the comparable period in 2017. For the year ended December 31, net sales decreased $1,576,000, or 6.8%, to $21,707,000 in 2018 from $23,283,000 in 2017. Net loss for the year ended December 31, 2018 was $ or $ per share, compared to $ or $ per share for the comparable period in 2017. The decrease in sales is primarily attributable to a ..." |
|
| 08/14/2018 |
8-K
| Quarterly results |
| 05/11/2018 |
8-K
| Quarterly results |
| 04/02/2018 |
8-K
| Quarterly results |
| 11/14/2017 |
8-K
| Quarterly results |
| 08/14/2017 |
8-K
| Quarterly results |
| 05/15/2017 |
8-K
| Form 8-K - Current report |
| 03/31/2017 |
8-K
| Form 8-K - Current report |
| 11/14/2016 |
8-K
| Quarterly results |
| 08/15/2016 |
8-K
| Quarterly results |
| 05/13/2016 |
8-K
| Quarterly results |
| 03/30/2016 |
8-K
| Quarterly results |
| 08/14/2013 |
8-K
| Quarterly results |
| 08/14/2012 |
8-K
| Quarterly results |
| 05/16/2012 |
8-K
| Quarterly results |
| 04/03/2012 |
8-K
| Form 8-K - Current report |
| 11/14/2011 |
8-K
| Form 8-K - Current report |
| 08/09/2011 |
8-K
| Form 8-K - Current report |
| 05/09/2011 |
8-K
| Quarterly results |
| 03/21/2011 |
8-K
| Form 8-K - Current report |
| 11/04/2010 |
8-K
| Form 8-K - Current report |
| 08/03/2010 |
8-K
| Form 8-K - Current report |
|
|
|